168 related articles for article (PubMed ID: 38798575)
1. Sex-specific single cell-level transcriptomic signatures of Rett syndrome disease progression.
Sharifi O; Haghani V; Neier KE; Fraga KJ; Korf I; Hakam SM; Quon G; Johansen N; Yasui DH; LaSalle JM
bioRxiv; 2024 May; ():. PubMed ID: 38798575
[TBL] [Abstract][Full Text] [Related]
2. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
3. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.
Young JI; Zoghbi HY
Am J Hum Genet; 2004 Mar; 74(3):511-20. PubMed ID: 14973779
[TBL] [Abstract][Full Text] [Related]
4. X-chromosome inactivation in rett syndrome human induced pluripotent stem cells.
Cheung AY; Horvath LM; Carrel L; Ellis J
Front Psychiatry; 2012; 3():24. PubMed ID: 22470355
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in Mecp2-mutant Rett syndrome model mice and the impact of cellular mosaicism in phenotype development.
Ribeiro MC; MacDonald JL
Brain Res; 2020 Feb; 1729():146644. PubMed ID: 31904347
[TBL] [Abstract][Full Text] [Related]
6. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
7. [X chromosome inactivation patterns in patients with Rett syndrome and their mothers and the parental origin of the priority inactive X chromosome].
Jiang SL; Bao XH; Song FY; Pan H; Li MR; Wu XR
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):648-52. PubMed ID: 17217653
[TBL] [Abstract][Full Text] [Related]
8. Sex disparate gut microbiome and metabolome perturbations precede disease progression in a mouse model of Rett syndrome.
Neier K; Grant TE; Palmer RL; Chappell D; Hakam SM; Yasui KM; Rolston M; Settles ML; Hunter SS; Madany A; Ashwood P; Durbin-Johnson B; LaSalle JM; Yasui DH
Commun Biol; 2021 Dec; 4(1):1408. PubMed ID: 34916612
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome.
Vogel Ciernia A; Yasui DH; Pride MC; Durbin-Johnson B; Noronha AB; Chang A; Knotts TA; Rutkowsky JR; Ramsey JJ; Crawley JN; LaSalle JM
Hum Mol Genet; 2018 Dec; 27(23):4077-4093. PubMed ID: 30137367
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in fifteen sporadic cases with Rett syndrome].
Zhu XW; Pan H; Li MR; Bao XH; Zhang JJ; Wu XR
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):565-9. PubMed ID: 19951486
[TBL] [Abstract][Full Text] [Related]
12. The MeCP2E1/E2-BDNF-
Pejhan S; Del Bigio MR; Rastegar M
Front Cell Dev Biol; 2020; 8():763. PubMed ID: 32974336
[TBL] [Abstract][Full Text] [Related]
13. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
14. Atypical Rett syndrome in a girl with mosaic triple X and MECP2 variant.
Takahashi S; Takeguchi R; Kuroda M; Tanaka R
Mol Genet Genomic Med; 2020 Mar; 8(3):e1122. PubMed ID: 31943886
[TBL] [Abstract][Full Text] [Related]
15. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
16. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
17. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
18. Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome.
Johnson BS; Zhao YT; Fasolino M; Lamonica JM; Kim YJ; Georgakilas G; Wood KH; Bu D; Cui Y; Goffin D; Vahedi G; Kim TH; Zhou Z
Nat Med; 2017 Oct; 23(10):1203-1214. PubMed ID: 28920956
[TBL] [Abstract][Full Text] [Related]
19. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent expression of MeCP2 in a heterozygous mosaic mouse model.
Smrt RD; Pfeiffer RL; Zhao X
Hum Mol Genet; 2011 May; 20(9):1834-43. PubMed ID: 21330301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
